DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
MARAC Advisory Statement: COVID-19 Vaccines
News is evolving rapidly about COVID-19 and COVID-19 vaccines. Early results from the COVID-19 vaccine trials are very promising, although the true benefits and risks will not be known until a larger number of people receive the vaccine.
The Centers for Disease Control and Prevention (CDC) lists sickle cell disease (SCD) as one of the populations vulnerable to severe COVID-19. Sickle cell disease raises the risk for serious problems with COVID-19, especially when compared to the same age in the general population.
Related Content
-
videos & visualsYou Should Get a COVID-19 Vaccine – Amharichttps://www.youtube.com/watch?v=79X6KZnN...
-
videos & visualsSCD/ Thalassaemia and COVID-19: Possible Risks and a Proposal for a Patient Pathway During the Pandemic – Webi...https://www.youtube.com/watch?v=ENKX7Kf6...
-
videos & visualsYou Should Get a COVID-19 Vaccine – Koreanhttps://www.youtube.com/watch?v=TCelzDdp...
-
news & eventsCOVID-19 and Sickle Cell Disease and Access to Care WebinarThe 14th Annual Sickle Cell Disease Rese...
-
news & eventsWhy I Will Be Getting the COVID-19 VaccineOn Nov. 9, Pfizer and BioNTech announced...
-
news & eventsIn Support of Rare Disease Patients Impacted by COVID-19, NORD Launches Premium and Limited Medical Relief ProgramUnited with more than 25 million America...
-
news & eventsCOVID-19 Vaccine Communication Toolkit for Community-Based OrganizationsThe toolkit is designed to help CBOs edu...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.